<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32484794</article-id>
<article-id pub-id-type="pmc">7406292</article-id>
<article-id pub-id-type="publisher-id">136857</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.136857</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex–associated cystic kidney disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7683-4448</contrib-id>
<name>
<surname>Nechama</surname>
<given-names>Morris</given-names>
</name>
<email>mnehama@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Makayes</surname>
<given-names>Yaniv</given-names>
</name>
<email>makayes@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Resnick</surname>
<given-names>Elad</given-names>
</name>
<email>eladhres@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meir</surname>
<given-names>Karen</given-names>
</name>
<email>karenm@hadassah.org.il</email>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5378-1045</contrib-id>
<name>
<surname>Volovelsky</surname>
<given-names>Oded</given-names>
</name>
<email>odedvo@hadassah.org.il</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Pediatric Nephrology Unit and</aff>
<aff id="A2"><label>2</label>Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.</aff>
<author-notes>
<corresp>Address correspondence to: Oded Volovelsky, Pediatric Nephrology Unit, Hadassah-Hebrew University Medical Center, Ein-Kerem Campus, Jerusalem, 91120, POB 12000, Israel. Phone: 972.2.6777023; Email: <email>odedvo@hadassah.org.il</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2020-07-09T09:00:00-0400" publication-format="electronic">
<day>9</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2020-07-09T09:00:00-0400" publication-format="electronic">
<day>9</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>7</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>5</volume>
<issue>13</issue>
<elocation-id>e136857</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/136857">This article is available online at https://insight.jci.org/articles/view/136857</self-uri>
<abstract>
<p>Chronic kidney disease is the main cause of mortality in patients with tuberous sclerosis complex (TSC) disease. The mechanisms underlying TSC cystic kidney disease remain unclear, with no available interventions to prevent cyst formation. Using targeted deletion of <italic>TSC1</italic> in nephron progenitor cells, we showed that cysts in <italic>TSC1-</italic>null embryonic kidneys originate from injured proximal tubular cells with high mTOR complex 1 activity. Injection of rapamycin to pregnant mice inhibited the mTOR pathway and tubular cell proliferation in kidneys of <italic>TSC1</italic>-null offspring. Rapamycin also prevented renal cystogenesis and prolonged the life span of TSC newborns. Gene expression analysis of proximal tubule cells identified sets of genes and pathways that were modified secondary to <italic>TSC1</italic> deletion and rescued by rapamycin administration during nephrogenesis. Inflammation with mononuclear infiltration was observed in the cystic areas of <italic>TSC1-</italic>null kidneys. Dexamethasone administration during pregnancy decreased cyst formation by not only inhibiting the inflammatory response, but also interfering with the mTORC1 pathway. These results reveal mechanisms of cystogenesis in TSC disease and suggest interventions before birth to ameliorate cystic disease in offspring.</p>
</abstract>
<abstract abstract-type="graphical">
<p>
<graphic orientation="portrait" position="float" xlink:href="jciinsight-5-136857-g288.jpg"></graphic>
</p>
</abstract>
<abstract abstract-type="toc">
<p>Administration of rapamycin or dexamethasone in pregnancy to a mouse model of tuberous sclerosis complex disease prevents cystic kidney disease in offspring.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Nephrology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Embryonic development</kwd>
<kwd>Mouse models</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Israel Science Foundation</funding-source>
<award-id>2358/18</award-id>
</award-group>
<award-group>
<funding-source>institutional grants from the Hadassah-Hebrew University Medical Center</funding-source>
<award-id>Startup</award-id>
<award-id>bridging grants</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>